SCHEMBL3561464

SCHEMBL3561464

CC(=O)n1c(-c2ccccc2)c(OCCN(C)C)c2cc(Br)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
KDM4E B2RXH2 6/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
TACR3 P29371 2/20 0.39
KCNH2 Q12809 1/20 0.39
BAZ2B Q9UIF8 1/20 0.39
MAPT P10636 1/20 0.38
SIGMAR1 Q99720 2/20 0.38
CCNE2 O96020 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSPO P30536 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
FGFR1 P11362 1/20 0.36
SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6820229 0.90 ALDH1A1 (0.43) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A
SCHEMBL3555919 0.87 KDM4E (0.45) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL3565673 0.87 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL3557475 0.86 HTR6 (0.45) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL3562785 0.85 ALDH1A1 (0.42) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A
SCHEMBL3567569 0.83 ALDH1A1 (0.43) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A
SCHEMBL3565558 0.81 HTR6 (0.46) ALDH1A1KDM4ELMNAHTR7
SCHEMBL3563780 0.81 KDM4E (0.45) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL3557215 0.81 HTR6 (0.43) ALDH1A1KDM4ELMNAHTR7
SCHEMBL14953594 0.79 KDM4E (0.41) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT ALDH1A1 1943/4885KDM4E 3751/4885LMNA 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.